...
College of Nursing > Faculty Funded Research
...
| Anchor | ||||
|---|---|---|---|---|
|
...
MICROBIOME AS POTENTIAL MEDIATOR IN PRETERM INFANT NEURODEVELOPMENT
Start Date unknown 9/21/2016
End Date unkown 8/31/2023
Preterm infants account for 12% of births, but disproportionately account for 40% of children who have cerebral palsy (CP), 25% of children with hearing impairment and 35% of those with vision impairment. Thus optimizing neurodevelopmental outcomes for preterm patients would have significant impact on outcome numbers for all children. Neurodevelopmental potential of the preterm infant is influenced by (i) Gestational age (GA), (ii) events in the neonatal intensive care unit, and (iii) care in the home environment after NICU discharge. This proposal will focus on understanding events that increase or decrease the risk of developmental impairment after an infant has been born preterm at a given gestational age, not on the prior exposures of prenatal and social factors that may have increased the risk of preterm birth. For a given infant, factors that caused preterm delivery are complete and fixed. Our goal is to instead focus on factors that are prospectively modifiable from the time of birth through early childhood in order to optimize a given infant’s neurodevelopmental potential. We will follow infants in two environments through two epochs – the neonatal intensive care unit (NICU) hospital course from birth to discharge and the home environment from NICU discharge through school readiness evaluation at four to six years of age. We will investigate the microbiome as a potential biologic effector of clinical and environmental factors associated with neurodevelopmental outcome in these epochs.
...
Dr. Maureen Groer & Velda Gonzalez-Marrero
FATIGUE AND THE GUT MICROBIOME OF PATIENTS RECEIVING CHEMORADIOTHERAPY FOR RECTAL CANCER
Start Date unknown 5/1/2017
End Date unkown 4/30/20
Fatigue is one of the most distressing and commonly reported side effects of chemo-radiation (CRT), with up to 78% of rectal cancer patients complaining of severe fatigue during CRT. While the etiology and associated mechanism of the cancer-related fatigue during CRT treatment remain elusive, it has been suggested that dysbiosis (an imbalance in the intestinal microbiota in the gut) may contribute to worsening of fatigue during a patients’ pelvic CRT. This study will contribute to address the knowledge gap in symptom research and the health literature by providing initial evidence of the biologic/gut microbial processes related to the relationship among CRT, dysbiosis, and fatigue in the rectal cancer population, so that more innovative and individualized interventions can be developed. The proposed research is guided by a model of chemotherapy-related side effects. The training plan was designed to allow the applicant to expand her theoretical knowledge and skills in symptom phenotyping and conducting bio-behavioral and microbiome research in order to meet the NRSA traineeship goals and launch a career as an independent nurse scientists. An experienced team of scientists will lead the research training plan as related to the following objectives: (1) to enhance her understanding of the science related to the proposed mechanism linking CRT-induced gut microbiome dysbiosis and fatigue; (2) to increase her understanding of the characterization of CRT-related fatigue phenotypes with patient biological and clinical data, and microbiome data collection techniques and analysis through a bedside-to-bench approach; (3) to obtain comprehensive training and knowledge in microbiome research including stool collection and processing, bacterial 16S rRNA amplicon sequencing, shotgun metagenomics analysis and interpretation of microbiome-derived metagenomics data; and (4) to improve scientific writing skills and building collaborations with experts in the field of bio-behavioral/symptom management/microbiome research to successfully publish in high-impact, peer-reviewed journals, and submit competitive grant applications. The training plan is for twenty four months and includes six core areas: didactic; interdisciplinary seminars; mentorship; laboratory training; research; and dissemination. The specific aims of the proposed study are to: Aim 1: Examine the temporal changes in diversity of the gut microbiome over the course of CRT of adults with localized rectal cancers. Aim 1a: To investigate whether the intensity of fatigue during CRT is associated with the gut microbial diversity changes during the course of treatment. Aim 2: Examine the temporal changes on the abundances of specific gut microbes of adults with localized rectal cancers over the course of CRT. Aim 2a: To investigate the associations between changes in the gut microbial abundance with changes in fatigue scores during the course of CRT. By focusing on the innovative investigation of the relationship between gut microbial changes and fatigue symptoms during CRT, this study aligns with the mission of NINR calling for studies on patient-centered bio-behavioral research that promote health and enhanced quality of life.
...
Dr. Cindy Tofthagen & Susan McMillan
ACCELERATED RESOLUTION THERAPY FOR TREATMENT OF COMPLICATED GRIEF IN SENIOR ADULTS
Start Date unknown pending
End Date unkown pending
Prolonged, complicated grief (PCG) is associated with increased risk of suicide, diminished physical and psychological health, and decreased physical, psychological, and role functioning among older adults. Grief interventions are primarily delivered by hospice organizations throughout the US. These programs are beneficial in the setting of normal grief; however, their usefulness for treatment of prolonged or complicated grief is limited and few treatment options exist for PCG outside of the 12 months of grief services that all Medicare-funded hospice organizations are required to provide. This uncontrolled, prospective study will examine accelerated resolution therapy (ART), a brief form of psychotherapy, as a treatment for PCG. Primary caregivers (age >60 years) of an immediate family member who died after enrollment in hospice, who indicate significant symptoms of PCG and psychological trauma, will receive 4-6 weekly sessions of ART. Assessment of grief, psychological trauma, sleep, anxiety, and depression will occur pre-treatment, at week 4, and at 1-month follow-up. As a secondary aim, we will examine changes in stress biomarkers salivary alpha-amylase and salivary interleukin 6, before and after ART. The data obtained will provide invaluable insight into potential dose of ART intervention, as well as anticipated outcomes.
...